The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125296321 12529632 1 I 20111206 20160706 20160706 EXP JP-CIPLA LTD.-2012JP00013 CIPLA 0.00 Y 0.00000 20160706 OT JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125296321 12529632 1 PS CARBOPLATIN. CARBOPLATIN 1 Unknown UNK 77383
125296321 12529632 2 SS Irinotecan IRINOTECAN 1 Unknown UNK U U 0 INFUSION
125296321 12529632 3 SS Irinotecan IRINOTECAN 1 Intravenous (not otherwise specified) 50 MG/M2, INFUSED ON DAY 1 AND 8, EVERY 21 DAYS U U 0 50 MG/M**2 INFUSION
125296321 12529632 4 SS CISPLATIN. CISPLATIN 1 Unknown UNK 0
125296321 12529632 5 SS ETOPOSIDE. ETOPOSIDE 1 Unknown UNK 0
125296321 12529632 6 SS Amrubicin AMRUBICIN 1 Intravenous (not otherwise specified) 100 MG/M2, 5-MINUTE INFUSION ON DAY 1 ALONE, EVERY 21 DAYS U U 0 100 MG/M**2 INFUSION
125296321 12529632 7 C Granulocyte colony stimulating factor (G-CSF) 2 Unknown UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125296321 12529632 1 Small cell lung cancer
125296321 12529632 2 Small cell lung cancer recurrent
125296321 12529632 4 Small cell lung cancer
125296321 12529632 5 Small cell lung cancer
125296321 12529632 6 Small cell lung cancer recurrent
125296321 12529632 7 Supportive care

Outcome of event

Event ID CASEID OUTC COD
125296321 12529632 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
125296321 12529632 Disease recurrence
125296321 12529632 Infection
125296321 12529632 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found